Technical Analysis for IMM - Immupharma Plc

Grade Last Price % Change Price Change
grade C 18.35 2.80% 0.50
IMM closed up 2.8 percent on Friday, December 13, 2019, on 1.46 times normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
See historical IMM trend table...

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 2.80%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 2.80%
NR7 Range Contraction 2.80%
Inside Day Range Contraction 2.80%
Wide Bands Range Expansion 2.80%
Older signals for IMM ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

ImmuPharma plc is a drug discovery and development company. The Company is focused on the development of drugs, primarily based on peptide therapeutics, to treat serious medical conditions such as autoimmune diseases. The Company has approximately five drug candidates in development, over two platform technologies and approximately 70 patents. Lupuzor is the Company's drug candidate and is a treatment for lupus, and life threatening auto immune disease. The Company's treatment for cancer, IPP-204106, has completed a Phase I/IIa study in cancer patients in France. Its compound IPP-102199 for pain relief is designed as a non-addictive replacement for morphine and other opioids, and is in pre-clinical development. Its treatment for inflammatory and allergic disorders (IPP-201007) is in early stage development. Its compound IPP-203101 is an antibiotic against methicillin-resistant staphylococcus aureus (MRSA) and other infections. The Company's research operations are in France.
Medicine Medical Specialties Cancer Drug Discovery Autoimmune Diseases Infectious Diseases Infections Antibiotics Bacterial Diseases Healthcare Associated Infections Staphylococcus Aureus Pain

Is IMM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 32.292
52 Week Low 6.91
Average Volume 1,881,174
200-Day Moving Average 10.99
50-Day Moving Average 11.73
20-Day Moving Average 15.49
10-Day Moving Average 19.99
Average True Range 3.38
ADX 42.09
+DI 27.84
-DI 13.76
Chandelier Exit (Long, 3 ATRs ) 22.15
Chandelier Exit (Short, 3 ATRs ) 17.05
Upper Bollinger Band 28.99
Lower Bollinger Band 2.00
Percent B (%b) 0.61
BandWidth 174.18
MACD Line 2.59
MACD Signal Line 2.68
MACD Histogram -0.0887
Fundamentals Value
Market Cap 16.26 Million
Num Shares 886 Thousand
EPS -0.03
Price-to-Earnings (P/E) Ratio -611.67
Price-to-Sales 13402.26
Price-to-Book 666.67
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.47
Resistance 3 (R3) 22.48 21.12 21.79
Resistance 2 (R2) 21.12 20.07 21.11 21.56
Resistance 1 (R1) 19.73 19.42 20.42 19.72 21.33
Pivot Point 18.37 18.37 18.71 18.36 18.37
Support 1 (S1) 16.98 17.32 17.68 16.98 15.37
Support 2 (S2) 15.62 16.67 15.61 15.14
Support 3 (S3) 14.23 15.62 14.91
Support 4 (S4) 14.23